This 3-part seminar series aims to prepare faculty when they are ready to take their invention or discovery to the clinic. In this final part of the series, Ben Vollrath, co-founder of Troy Therapeutics (a USC spinout), COO of Amprion Inc., and former CEO of Xetrios Therapeutics will discuss examples of successes and failures, as well as the biggest challenges facing academic researchers interested in translation.  

Part of the Center for Excellence in Research (CER) Fall 2018 Mentoring Events, brought to you by SC CTSI and the MESH Academy